257 related articles for article (PubMed ID: 10600331)
41. Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand.
Mach N; Gillessen S; Wilson SB; Sheehan C; Mihm M; Dranoff G
Cancer Res; 2000 Jun; 60(12):3239-46. PubMed ID: 10866317
[TBL] [Abstract][Full Text] [Related]
42. Immunopathology of metastases in patients of colorectal carcinoma treated with monoclonal antibody 17-1A and granulocyte macrophage colony-stimulating factor.
Shetye J; Ragnhammar P; Liljefors M; Christensson B; Frödin JE; Biberfeld P; Mellstedt H
Clin Cancer Res; 1998 Aug; 4(8):1921-9. PubMed ID: 9717820
[TBL] [Abstract][Full Text] [Related]
43. A Phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen.
Morse MA; Deng Y; Coleman D; Hull S; Kitrell-Fisher E; Nair S; Schlom J; Ryback ME; Lyerly HK
Clin Cancer Res; 1999 Jun; 5(6):1331-8. PubMed ID: 10389916
[TBL] [Abstract][Full Text] [Related]
44. Infusion of unpulsed dendritic cells derived from granulocyte/macrophage colony-stimulating factor-mobilized peripheral blood CD34+ cells and monocytes in patients with advanced carcinoma.
Triozzi PL; Kim J; Aldrich W
J Hematother Stem Cell Res; 2003 Jun; 12(3):279-87. PubMed ID: 12857369
[TBL] [Abstract][Full Text] [Related]
45. Immunomodulation of Bu-Zhong-Yi-Qi-Tang on in vitro granulocyte colony-stimulating-factor and tumor necrosis factor-alpha production by peripheral blood mononuclear cells.
Kao ST; Yang SL; Hsieh CC; Yang MD; Wang TF; Lin JG
Immunopharmacol Immunotoxicol; 2000 Nov; 22(4):711-20. PubMed ID: 11105783
[TBL] [Abstract][Full Text] [Related]
46. Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. Implications for sustained dendritic cell activation in the skin.
Pastore S; Fanales-Belasio E; Albanesi C; Chinni LM; Giannetti A; Girolomoni G
J Clin Invest; 1997 Jun; 99(12):3009-17. PubMed ID: 9185525
[TBL] [Abstract][Full Text] [Related]
47. Peripheral blood mononuclear mobilization with sargramostim (GM-CSF).
Ahmed T; Preti RA; Razis E; Farley T; Lake DE; Beer M; Cook P; Ciavarella D
Prog Clin Biol Res; 1994; 389():457-62. PubMed ID: 7535454
[No Abstract] [Full Text] [Related]
48. [Phase I trial of recombinant human granulocyte-macrophage colony stimulating factor. Results in patients with advanced tumors].
Berthaud P; Eugène-Jolchine I; Spielmann M; Le Chevalier T; Tursz T
Bull Cancer; 1993 May; 80(5):418-30. PubMed ID: 8173195
[TBL] [Abstract][Full Text] [Related]
49. Aerosol granulocyte macrophage-colony stimulating factor: a low toxicity, lung-specific biological therapy in patients with lung metastases.
Anderson PM; Markovic SN; Sloan JA; Clawson ML; Wylam M; Arndt CA; Smithson WA; Burch P; Gornet M; Rahman E
Clin Cancer Res; 1999 Sep; 5(9):2316-23. PubMed ID: 10499599
[TBL] [Abstract][Full Text] [Related]
50. Possible biological indicators of the response to recombinant tumour necrosis factor alpha in patients with advanced neoplasms.
Braczkowski R; Zubelewicz B; Romanowski W; Lissoni P; Brivio F
J Exp Clin Cancer Res; 1998 Sep; 17(3):349-54. PubMed ID: 9894774
[TBL] [Abstract][Full Text] [Related]
51. Epidermal Langerhans cells from mice bearing a granulocyte macrophage-colony stimulating factor-producing mammary tumor display impaired accessory functions.
Xie Y; Fernandez ME; Streilein JW; Lopez DM
Anticancer Res; 1996; 16(1):9-16. PubMed ID: 8615675
[TBL] [Abstract][Full Text] [Related]
52. Blood cell redistribution in the lung after administration of recombinant human granulocyte-macrophage colony-stimulating factor.
Gatti E; Scagliotti GV; Ferrari G; Mutti L; Pozzi E; Stacchini A; Fubini L; Aglietta M
Eur Respir J; 1995 Sep; 8(9):1566-71. PubMed ID: 8575586
[TBL] [Abstract][Full Text] [Related]
53. Alterations in phenotype and cell-surface antigen expression levels of human monocytes: differential response to in vivo administration of rhM-CSF or rhGM-CSF.
Schmid I; Baldwin GC; Jacobs EL; Isacescu V; Neagos N; Giorgi JV; Glaspy JA
Cytometry; 1995 Jun; 22(2):103-10. PubMed ID: 7587740
[TBL] [Abstract][Full Text] [Related]
54. Recombinant human granulocyte-macrophage colony-stimulating factor plus erythropoietin for the treatment of cytopenias in patients with myelodysplastic syndromes.
Stasi R; Pagano A; Terzoli E; Amadori S
Br J Haematol; 1999 Apr; 105(1):141-8. PubMed ID: 10233377
[TBL] [Abstract][Full Text] [Related]
55. Interleukin-1 but not tumour necrosis factor alpha synergistically upregulates the granulocyte-macrophage colony-stimulating factor-induced B7-1 expression of murine Langerhans cells.
Furue M; Chang CH; Tamaki K
Br J Dermatol; 1996 Aug; 135(2):194-8. PubMed ID: 8881659
[TBL] [Abstract][Full Text] [Related]
56. Phase I dose-escalation study of tumor necrosis factor-alpha and concomitant radiation therapy.
Hallahan DE; Vokes EE; Rubin SJ; O'Brien S; Samuels B; Vijaykumar S; Kufe DW; Phillips R; Weichselbaum RR
Cancer J Sci Am; 1995; 1(3):204-9. PubMed ID: 9166477
[TBL] [Abstract][Full Text] [Related]
57. [Experimental study on the immune functions of splenic dendritic cells after a combined therapy of cryoablation and granulocyte macrophage-colony stimulating factor for prostate cancer].
Si TG; Guo Z; Wang HT; Liu CF; Yang M
Zhonghua Yi Xue Za Zhi; 2011 May; 91(17):1184-7. PubMed ID: 21756772
[TBL] [Abstract][Full Text] [Related]
58. Development of a successful antitumor therapeutic model combining in vivo dendritic cell vaccination with tumor irradiation and intratumoral GM-CSF delivery.
Driessens G; Nuttin L; Gras A; Maetens J; Mievis S; Schoore M; Velu T; Tenenbaum L; Préat V; Bruyns C
Cancer Immunol Immunother; 2011 Feb; 60(2):273-81. PubMed ID: 21076828
[TBL] [Abstract][Full Text] [Related]
59. Intradermal transgenic expression of granulocyte-macrophage colony-stimulating factor induces neutrophilia, epidermal hyperplasia, Langerhans' cell/macrophage accumulation, and dermal fibrosis.
Xing Z; Gauldie J; Tremblay GM; Hewlett BR; Addison C
Lab Invest; 1997 Dec; 77(6):615-22. PubMed ID: 9426399
[TBL] [Abstract][Full Text] [Related]
60. Possible role of tumor necrosis factor-alpha in erythropoietic suppression by endotoxin and granulocyte/macrophage colony-stimulating factor.
Udupa KB; Sharma BG
Am J Hematol; 1996 Jul; 52(3):178-83. PubMed ID: 8756083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
